Literature DB >> 2838862

Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol.

R Oishi1, Y Itoh, M Nishibori, K Saeki, S Ueki.   

Abstract

The effect of alpha-fluoromethylhistidine (alpha-FMH), a specific inhibitor of histidine decarboxylase, on the potentiation of thiopental-induced sleep by delta 9-tetrahydrocannabinol (THC), which inhibits the histamine turnover in the brain, was examined in mice and rats. The sleeping time after injection of thiopental sodium (40 mg/kg, IV) was prolonged by THC (10 mg/kg, IP, 1 h before) to approximately twice the control value. alpha-FMH (50 mg/kg, IP) administered alone had no significant influence on the thiopental sleeping time. However, alpha-FMH given 1 or 3 h before THC treatment markedly enhanced the THC potentiation of thiopental-induced sleep. Such an enhancement by alpha-FMH was not observed when alpha-FMH was administered 15 h before THC treatment. The brain histamine level decreased by 60% during the first 4 h after alpha-FMH injection and remained low until 15 h after the treatment. The thiopental sleep-potentiating action of morphine, chlorpromazine and diazepam was not affected by pretreatment with alpha-FMH. The transient enhancing effect of alpha-FMH on the THC potentiation of thiopental-induced sleep suggests that the histaminergic system is one of the activating transmitter systems in the brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838862     DOI: 10.1007/BF00212771

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

Review 1.  Interactions of delta9-tetrahydrocannabinol with other drugs.

Authors:  L E Hollister
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.

Authors:  R Oishi; Y Itoh; M Nishibori; K Saeki
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

3.  Effects of (--)delta-9-trans-tetrahydrocannabinol in man.

Authors:  H Isbell; C W Gorodetzsky; D Jasinski; U Claussen; F von Spulak; F Korte
Journal:  Psychopharmacologia       Date:  1967

4.  Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol.

Authors:  T Yamauchi; Y Shoyama; H Aramaki; T Azuma; I Nishioka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-07       Impact factor: 1.645

5.  Selective inhibitors of biosynthesis of aminergic neurotransmitters.

Authors:  J Kollonitsch; L M Perkins; A A Patchett; G A Doldouras; S Marburg; D E Duggan; A L Maycock; S D Aster
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

Review 6.  Cannabis: review of behavioral effects in animals.

Authors:  L L Miller; W G Drew
Journal:  Psychol Bull       Date:  1974-07       Impact factor: 17.737

7.  Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues.

Authors:  K Maeyama; T Watanabe; Y Taguchi; A Yamatodani; H Wada
Journal:  Biochem Pharmacol       Date:  1982-07-15       Impact factor: 5.858

8.  Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies.

Authors:  M Garbarg; G Barbin; E Rodergas; J C Schwartz
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

9.  Histamine-induced arousal in the conscious and pentobarbital-pretreated rat.

Authors:  P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

10.  Morphine-induced changes in histamine dynamics in mouse brain.

Authors:  M Nishibori; R Oishi; Y Itoh; K Saeki
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.